Literature DB >> 2140550

Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview.

H Gavras1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2140550     DOI: 10.2165/00003495-199000392-00014

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  12 in total

Review 1.  The role of calcium channel blockers in the treatment of hypertension.

Authors:  A K Halperin; L X Cubeddu
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

Review 2.  Calcium channel blockers in the management of arterial hypertension.

Authors:  T Thomas; D G Vidt
Journal:  Cleve Clin J Med       Date:  1987 Nov-Dec       Impact factor: 2.321

3.  Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.

Authors:  O A Carretero; S Miyazaki; A G Scicli
Journal:  Hypertension       Date:  1981 Jan-Feb       Impact factor: 10.190

4.  Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.

Authors:  A Benetos; H Gavras; J M Stewart; R J Vavrek; S Hatinoglou; I Gavras
Journal:  Hypertension       Date:  1986-11       Impact factor: 10.190

5.  Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients.

Authors:  M H Weinberger
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  Angiotensin-converting enzyme inhibition: renal aspect.

Authors:  N K Hollenberg
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases.

Authors:  M Bursztyn; E Grossman; T Rosenthal
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Cardiovascular effects of verapamil in patients with essential hypertension.

Authors:  R E Schmieder; F H Messerli; G E Garavaglia; B D Nunez
Journal:  Circulation       Date:  1987-05       Impact factor: 29.690

10.  Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.

Authors:  W Frishman; S Charlap; B Kimmel; M Teicher; J Cinnamon; L Allen; J Strom
Journal:  Circulation       Date:  1988-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.